First Wilshire Securities Management Inc Bristol Myers Squibb CO Transaction History

First Wilshire Securities Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $206,967 - $227,943	-2,850 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $175,218 - $210,102	2,850 New	2,850 $208,000
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $186,385 - $218,326	-3,150 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$61.91 - $67.42 $195,016 - $212,373	3,150 New	3,150 $210,000
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $222,525 - $250,274	-3,750 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$57.74 - $65.43 $216,525 - $245,362	3,750 New	3,750 $233,000

2,668

1.58B

26.1M

23.8M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $97.7B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of First Wilshire Securities Management Inc, based on Form 13F filings with the SEC.

Stay updated on First Wilshire Securities Management Inc with notifications on news.